| 52 Week Rng | - |
| Market Cap | - |
| Avg Volume | - |
| 1M Volatility | - |
| Short Ratio | - |
| P/E Ratio (TTM) | - |
| P/E Ratio (Fwd) | - |
| P/B Ratio | - |
| Div & Yield | - |
brandcommand11 • Starting Small • Mar 2020
Automatic trade executed by Stockfuse to ensure margin compliance.
RHTrader • Long Term Favorites Large Cap • Mar 2020
Automatic trade executed by Stockfuse to ensure margin compliance.
kone_alfa • OLD|Aalto Investment Management Game (Spring 2020) • Mar 2020
Automatic trade executed by Stockfuse to ensure margin compliance.
awink • Starting Small • Mar 2020
Automatic trade executed by Stockfuse to ensure margin compliance.
WinCapitaHolding • OLD|Aalto Investment Management Game (Spring 2020) • Jan 2020
The fund follows the return seasonality strategy by investing into stocks with exceptionally high or low returns during the same-calendar-months. Monthly rebalancing, thus the fund closes its position.
WSK • OLD|Aalto Investment Management Game (Spring 2020) • Jan 2020
Portfolio consists of 20 biotechnology/pharmaceutical corporations' stocks. Equal weighting | Passive buy and hold strategy, long term.
Incyte corporation is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Its beta is 0.95 which is slightly under the market beta. Earnings are forecast to grow 27,55% per year. So the company is good and stable, but still have great growing situation.